Beryl Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Beryl Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-478,755	Closed	-$25.2M	–	15
2026 Q1	$25.2M	Buy	+478,755	New	+$19.7M	23%	2

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Beryl Capital Management's TERN Position: Q2 2026 in Review

Beryl Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 478,755 shares — an estimated $25.2M sold.

Beryl Capital Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $25.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Beryl Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Beryl Capital Management sold 478,755 Terns Pharmaceuticals shares in Q2 2026, an estimated $25.2M.
Beryl Capital Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Beryl Capital Management's Terns Pharmaceuticals position peaked at $25.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Beryl Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.